SCHEMBL5373563

SCHEMBL5373563

CS(=O)(=O)c1cccc(O)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
CDK2 P24941 1/20 0.42
STAT3 P40763 1/20 0.38
CCR2 P41597 1/20 0.38
BCAT2 O15382 1/20 0.36
HSD11B1 P28845 1/20 0.36
THRB P10828 1/20 0.35
ENPP2 Q13822 1/20 0.35
MCOLN3 Q8TDD5 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ESR1 P03372 1/20 0.35
GAA P10253 1/20 0.35
ESR2 Q92731 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MAOA P21397 1/20 0.34
ALPL P05186 1/20 0.34
ALPI P09923 1/20 0.34
ALPG P10696 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5728048 0.81 TSHR (0.48) TSHRCDK2STAT3MEN1KMT2A
SCHEMBL28298733 0.81 CYP3A4 (0.44) TSHRCCR2ENPP2ALDH1A1L3MBTL1
SCHEMBL29184247 0.79 TSHR (0.46) TSHRCDK2STAT3PTGES2ALDH1A1
SCHEMBL6828498 0.78 CDK2 (0.48) CDK2STAT3BCAT2THRBENPP2
SCHEMBL2633428 0.78 MCOLN3 (0.53) TSHRCCR2HSD11B1MCOLN3KMT2A
SCHEMBL71032 0.78 BCAT2 (0.44) TSHRCDK2STAT3BCAT2ENPP2
SCHEMBL1577598 0.77 TRPA1 (0.48) TSHRCDK2STAT3BCAT2THRB
SCHEMBL28650941 0.77 HSD11B1 (0.40) TSHRCCR2HSD11B1MCOLN3KMT2A
SCHEMBL9359459 0.75 CDK2 (0.47) CDK2STAT3BCAT2THRBENPP2
SCHEMBL2781407 0.75 CA1 (0.43) TSHRCCR2BCAT2HSD11B1MCOLN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205409-B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBOTT LABORATORIES (US) 2007-04-17 US disclosed
US-20050131019-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBVIE INC. 2005-06-16 US disclosed
WO-2005023762-A1 PYRROLIDINE-2-CARBONITRILE DERIVATIVES AND THEIR USE AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) ABBOTT LABORATORIES (US) 2005-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131019-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) DPP4, DPP3, DPP7 TSHR 2619/4885CDK2 2389/4885STAT3 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.